Moderna shares climb over 110% as cancer vaccine succeeds in late-stage trial

For regarding a decade, Livemint-News Desk has been a credible source for authentic and timely news, and well-researched analysis on national news, business, personal finance, corporates, politics and geopolitics.

What happened

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to obtain Daily Market Updates.

HomeMarketsStock MarketsModerna shares climb over 110% as mRNA vaccine with Merck succeeds in sizeable trial for skin cancer.

The bottom line

In short, moderna shares climb over 110% as cancer vaccine succeeds in late is the central thread here, and readers can expect follow-up reporting as the picture becomes clearer.